[1]
|
S. P. Mankoff, C. Brander, S. Ferrone and F. M. Marincola, “Lost in Translation: Obstacles to Translational Medicine,” Journal of Translational Medicine, Vol. 2, No. 1, 2004, pp. 14-18.
|
[2]
|
X. G. Sun, Q. Liu, Y. Y. Zhao and Y. Cai, “Confirmation, Falsification, or Hermeneutics?” Journal of Nanjing University of Traditional Chinese Medicine (Social Science Edition), Vol. 8, No. 1, 2007, pp. 30-33.
|
[3]
|
J. Xu and Y. Yang, “Traditional Chinese Medicine in the Chinese Health Care System,” Health Policy, Vol. 90, No. 2-3, 2009, pp. 133-139.
dx.doi.org/10.1016/j.healthpol.2008.09.003
|
[4]
|
B. Wu, M. Liu, H. Liu, W. Li, S. Tan, S. Zhang, et al., “Meta-Analysis of Traditional Chinese Patent Medicine for Ischemic Stroke,” Stroke, Vol. 38, No. 6, 2007, pp. 1973-1979.
|
[5]
|
X. G. Sun, “The Negative Influences of Pragmatism on Traditional Chinese Medicine (TCM),” Medicine and Philosophy, Vol. 19, No. 9, 1998, pp. 19-21.
|
[6]
|
B. Liu, Y. Zhang, J. Hu, L. He and X. Zhou, “Thinking and Practice of Accelerating Transformation of Traditional Chinese Medicine from Experience Medicine to Evidence-Based Medicine,” Frontier Medical, Vol. 5, No. 2, 2011, pp. 163-170.
dx.doi.org/10.1007/s11684-011-0143-9
|
[7]
|
R. L. Hauger, V. Risbrough, R. H. Oakley, J. A. Olivares-Reyes and F. M. Dautzenberg, “Role of CRF Receptor Signaling in Stress Vulnerability, Anxiety, and Depression,” Annals of the New York Academy of Sciences, Vol. 1179, No. 2009, pp. 120-143.
|
[8]
|
M. W. Saif, F. Lansigan, S. Ruta, L. Lamb, M. Mezes, K. Elligers, et al., “Phase I Study of the Botanical Formulation PHY906 with Capecitabine in Advanced Pancreatic and Other Gastrointestinal Malignancies,” Phytomedicine, Vol. 17, No. 3-4, 2010, pp. 161-169.
|
[9]
|
Y. Yen, S. So, M. Rose, M. W. Saif, E. Chu, S. H. Liu, et al., “Phase I/II Study of PHY906/Capecitabine in Advanced Hepatocellular Carcinoma,” Anticancer Research, Vol. 29, No. 10, 2009, pp. 4083-4092.
|
[10]
|
X. Huang, F. Qin, H. M. Zhang, H. B. Xiao, L. X. Wang, X. Y. Zhang, et al., “Cardioprotection by Guanxin II in Rats with Acute Myocardial Infarction Is Related to Its Three Compounds,” Journal of Ethnopharmacology, Vol. 121, No. 2, 2009, pp. 268-273.
dx.doi.org/10.1016/j.jep.2008.10.029
|
[11]
|
R. Tilton, A. A. Paiva, J. Q. Guan, R. Marathe, Z. Jiang, W. van Eyndhoven, et al., “A Comprehensive Platform for Quality Control of Botanical Drugs (Phytomicsqc): A Case Study of Huangqin Tang (HQT) and PHY906,” Chinese Medicine, Vol. 5, 2010, pp. 1-15.
dx.doi.org/10.1186/1749-8546-5-30
|
[12]
|
Y. Sun, Y. Dong, H. J. Jiang, T. T. Cai, L. Chen, X. Zhou, et al., “Dissection of the Role of Paeoniflorin in the Traditional Chinese Medicinal Formula Si-Ni-San against Contact Dermatitis in Mice,” Life Sciences, Vol. 84, No. 11-12, 2009, pp. 337-344.
dx.doi.org/10.1016/j.lfs.2008.12.023
|
[13]
|
Y. Wang, X. Huang, F. Qin, P. Ren, Z. Zhu, R. Fan, et al., “A Strategy for Detecting Optimal Ratio of Cardioprotection-Dependent Three Compounds as Quality Control of Guan-Xin-Er-Hao Formula,” Journal of Ethnopharmacology, Vol. 133, No. 2, 2011, pp. 735-742.
dx.doi.org/10.1016/j.jep.2010.11.006
|
[14]
|
Y. Li, T. Wu, H. Shang and K. Yang, “Strategies for Promoting the Development of Evidence-Based Medicine in China,” Journal of Evidence-Based Medicine, Vol. 2, No. 1, 2009, pp. 47-52.
dx.doi.org/10.1111/j.1756-5391.2009.01012.x
|
[15]
|
M. U. Naidu, “Promise of Translational Medicine: An Evidence-Based Therapeutics,” Indian Journal of Pharmacology, Vol. 43, No. 2, 2011, pp. 103-104.
dx.doi.org/10.4103/0253-7613.77332
|
[16]
|
G. K. Merijohn and M. G. Newman, “The Translational Clinical Practice System: A Way to Implement the Evidence-Based Approach in the Dental Office,” Journal of the California Dental Association, Vol. 34, No. 7, 2006, pp. 529-539.
|
[17]
|
A. Terzic and S. A. Waldman, “Translational Medicine: Path to Personalized and Public Health,” Biomarkers in Medicine, Vol. 4, No. 6, 2010, pp. 787-790.
dx.doi.org/10.2217/bmm.10.101
|
[18]
|
M. Wehling, “Translational Medicine: Science or Wishful Thinking?” Journal of Translational Medicine, Vol. 6, No. 3, 2008, pp. 1-3.
|